Benzinga | Sep 17, 2020 11:52AM EDT

Zynerba Pharmaceuticals Shares Spike Higher; FDA Issues Orphan Drug Designation For Cannabidiol For Treatment Of 22q.11.2 Deletion Syndrome

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=20207638